B. Metzler Seel. Sohn & Co. Holding Ag Medpace Holdings, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 9,280 shares of MEDP stock, worth $3.16 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,280
Previous 13,313
30.29%
Holding current value
$3.16 Million
Previous $2.52 Million
122823.17%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding MEDP
# of Institutions
618Shares Held
25.1MCall Options Held
42.8KPut Options Held
207K-
Black Rock Inc. New York, NY2.58MShares$878 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$867 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$310 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$256 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$214 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.6B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...